Structural basis of metallo-β-lactamase resistance to taniborbactam

被引:6
|
作者
Drusin, Salvador I. [1 ]
Le Terrier, Christophe [2 ,3 ]
Poirel, Laurent [2 ,4 ]
Bonomo, Robert A. [5 ,6 ,7 ,8 ,9 ,10 ,11 ]
Vila, Alejandro J. [1 ,11 ,12 ]
Moreno, Diego M. [1 ,13 ]
机构
[1] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Rosario, Argentina
[2] Univ Fribourg, Fac Sci & Med, Emerging Antibiot Resistance, Med & Mol Microbiol, Fribourg, Switzerland
[3] Univ Hosp Geneva, Div Intens Care Unit, Geneva, Switzerland
[4] Swiss Natl Reference Ctr Emerging Antibiot Resista, Fribourg, Switzerland
[5] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Res Serv & GRECC, Cleveland, OH USA
[6] Univ Hosp Cleveland Med Ctr, Dept Med, Cleveland, OH USA
[7] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH USA
[8] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH USA
[9] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH USA
[10] Case Western Reserve Univ, Sch Med, Dept Prote & Bioinformat, Cleveland, OH USA
[11] CWRU Cleveland VAMC Ctr Antimicrobial Resistance &, Cleveland, OH 44106 USA
[12] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, CONICET, Rosario, Argentina
[13] Univ Nacl Rosario, Inst Quim Rosario IQUIR, CONICET, Rosario, Argentina
基金
美国国家卫生研究院;
关键词
taniborbactam resistance; metallo-beta-lactamases; NDM-9; CARBAPENEM-RESISTANT; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; INHIBITORS; ACCURACY; NDM-9;
D O I
10.1128/aac.01168-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The design of inhibitors against metallo-beta-lactamases (MBLs), the largest family of carbapenemases, has been a strategic goal in designing novel antimicrobial therapies. In this regard, the development of bicyclic boronates, such as taniborbactam (TAN) and xeruborbactam, is a major achievement that may help in overcoming the threat of MBL-producing and carbapenem-resistant Gram-negative pathogens. Of concern, a recent report has shown that New Delhi MBL-9 (NDM-9) escapes the inhibitory action of TAN by a single amino acid substitution with respect to New Delhi MBL-1 (NDM-1), the most widely disseminated MBL. Here, we report a docking and computational analysis that identifies that "escape variants" against TAN can arise by disruption of the electrostatic interaction of negative charges in the active site loops of MBLs with the N-(2-aminoethyl)cyclohexylamine side chain of TAN. These changes result in non-productive binding modes of TAN that preclude reaction with the MBLs, a phenomenon that is not restricted to NDM-9. This analysis demonstrates that single amino acid substitutions in non-essential residues in MBL loops can unexpectedly elicit resistance to TAN.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers
    Brem, Juergen
    van Berkel, Sander S.
    Zollman, David
    Lee, Sook Y.
    Gileadi, Opher
    McHugh, Peter J.
    Walsh, Timothy R.
    McDonough, Michael A.
    Schofield, Christopher J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 142 - 150
  • [2] Heteroresistance to cefepime- taniborbactam in metallo-β-lactamase- encoding Enterobacterales
    Abbott, Carter
    Satola, Sarah W.
    Weiss, David
    LANCET INFECTIOUS DISEASES, 2023, 23 (08): : E277 - E278
  • [3] Structural Basis of Metallo-β-lactamase Inhibition by N-Sulfamoylpyrrole-2-carboxylates
    Farley, Alistair J. M.
    Ermolovich, Yuri
    Calvopina, Karina
    Rabe, Patrick
    Panduwawala, Tharindi
    Brem, Jurgen
    Bjorkling, Fredrik
    Schofield, Christopher J.
    ACS INFECTIOUS DISEASES, 2021, 7 (06): : 1809 - 1817
  • [4] Targeting metallo-β-lactamase enzymes in antibiotic resistance
    King, Dustin T.
    Strynadka, Natalie C. J.
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (11) : 1243 - 1263
  • [5] Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
    Andrew M. King
    Sarah A. Reid-Yu
    Wenliang Wang
    Dustin T. King
    Gianfranco De Pascale
    Natalie C. Strynadka
    Timothy R. Walsh
    Brian K. Coombes
    Gerard D. Wright
    Nature, 2014, 510 : 503 - 506
  • [6] Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
    King, Andrew M.
    Reid-Yu, Sarah A.
    Wang, Wenliang
    King, Dustin T.
    De Pascale, Gianfranco
    Strynadka, Natalie C.
    Walsh, Timothy R.
    Coombes, Brian K.
    Wright, Gerard D.
    NATURE, 2014, 510 (7506) : 503 - +
  • [7] Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance
    King, Dustin
    Strynadka, Natalie
    PROTEIN SCIENCE, 2011, 20 (09) : 1484 - 1491
  • [8] Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases
    Le Terrier, Christophe
    Viguier, Clement
    Nordmann, Patrice
    Vila, Alejandro J.
    Poirel, Laurent
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (02)
  • [9] Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
    Brem, Juergen
    Cain, Ricky
    Cahill, Samuel
    McDonough, Michael A.
    Clifton, Ian J.
    Jimenez-Castellanos, Juan-Carlos
    Avison, Matthew B.
    Spencer, James
    Fishwick, Colin W. G.
    Schofield, Christopher J.
    NATURE COMMUNICATIONS, 2016, 7
  • [10] Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
    Jürgen Brem
    Ricky Cain
    Samuel Cahill
    Michael A. McDonough
    Ian J. Clifton
    Juan-Carlos Jiménez-Castellanos
    Matthew B. Avison
    James Spencer
    Colin W. G. Fishwick
    Christopher J. Schofield
    Nature Communications, 7